Last edition
News about "OXB"
OXB Signs Multi-Year Commercial Supply Deal with Bristol Myers Squibb
Oxford Biomedica will serve as the commercial manufacturer of lentiviral vectors for Bristol Myers Squibb’s CAR-T programmes under a new multi-year supply agreement, which includes a five-year initial term with an option to extend.
OXB | 05/02/2026 | By News Bureau | 195
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members